Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

OxSAT 100

K-Number: K191574 · 2020-04-09

ApplicantS.L.P. , Ltd.
Decision Date2020-04-09
Product CodeDQA
Advisory CommitteeCV
DecisionSubstantially Equivalent

Device Summary

OxSAT 100 is a medical device manufactured by S.L.P. , Ltd.. It received FDA 510(k) clearance on 2020-04-09 under approval number K191574. The device is classified under product code DQA. It was reviewed by the CV advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the OxSAT 100?

OxSAT 100 is a medical device that received FDA 510(k) clearance on 2020-04-09. It is manufactured by S.L.P. , Ltd.. The 510(k) number is K191574.

When was OxSAT 100 approved by the FDA?

OxSAT 100 received FDA 510(k) clearance on 2020-04-09, under approval number K191574.

What company makes OxSAT 100?

OxSAT 100 is manufactured by S.L.P. , Ltd..

What is the FDA product code for OxSAT 100?

The FDA product code for OxSAT 100 is DQA.

Related Devices (Code: DQA)

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.